Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4 pseudogene 31 (MTND4P31) is a pseudogene; it is a genomic DNA segment with sequence similarity to the functional MT-ND4 gene but does not produce a functional protein. Pseudogenes generally arise through gene duplication or retrotransposition events followed by the accumulation of disabling mutations. MTND4P31 is annotated as a non-functional copy and does not have established roles in biological function, disease, or as a therapeutic target[7].\n\nThis entry is not considered a therapeutic target such as a receptor, enzyme, transporter, or transcription factor. There is no evidence in the literature or genetic databases for MTND4P31 being involved in disease, response to drugs, or other molecular functions—it is simply considered a nonfunctional sequence related to the mitochondrial ND4 gene[7].\n\nIf you are seeking information about the functional, protein-coding mitochondrial gene, refer to \"NADH-ubiquinone oxidoreductase chain 4\" (abbreviated as MT-ND4 or ND4), which is an integral component of mitochondrial complex I, involved in electron transport and energy production, and implicated in diseases such as Leber hereditary optic neuropathy[1][2][3][4][5]. However, \"MT-ND4 pseudogene 31\" is not equivalent to MT-ND4, and does not share those biological or therapeutic significances[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4 pseudogene 31 (MTND4P31).